← Leaderboards
Anjaparavanda P Naren
University Of Tennessee Health Sci Ctr
$16,948,975
Attributed
$18,074,258
Total exposure
15
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,010,543 · 16
By mechanism
R01$13,052,108 · 5
P30$12,717,623 · 7
UG3$636,000 · 1
UH3$357,751 · 1
R03$144,613 · 1
R56$102,448 · 1
Top collaborators
- John Paul Clancy10 shared
- Jeffrey A Whitsett8 shared
- Raouf S Amin3 shared
- Michael A Helmrath3 shared
- Anil Jegga3 shared
- Gary Lewis Mcphail1 shared
Most similar at University Of Tennessee Health Sci Ctr
Same institution · by research overlap
- Gabor J Tigyi$24,190,037
- Jur Strobos$539,515
- Shadab A Siddiqi$4,044,318
Others in their field
Top investigators on “Cystic Fibrosis Transmembrane Conductance Regulator”
- John F Engelhardt · University Of Iowa$19,572,056
- David A Stoltz · University Of Iowa$19,554,520
- Joseph Zabner · University Of Iowa$16,996,052
- Paul B McCray · University Of Iowa$15,787,286
- Garry R Cutting · Johns Hopkins University$14,051,583
- Steven Mark Rowe · University Of Alabama At Birmingham$13,553,382
Research focus
Cystic Fibrosis Transmembrane Conductance RegulatorCellsIntestinesEpithelial CellsCystic FibrosisDiarrheaComplexMacromolecular ComplexesCystic Fibrosis PatientsFluids And SecretionsMediatingApplications GrantsResearch PersonnelCell MembraneClinically RelevantCyclic AmpProtein Protein InteractionApicalMutationAffectIn VitroChloride ChannelsLifeAgonist
Grant awards (72)
Personalized Cystic Fibrosis Therapy and Research Center$1,248,906
P30 · FY2025 · DK · contact PI
Inhibition of an Apical cAMP/cGMP Transporter (MRP4) in the Gut Induces Diarrhea$579,373
R01 · FY2025 · DK · contact PI
CYSTIC FIBROSIS RELATED DISEASE MODEL CORE - Core 3- Naren$382,537
P30 · FY2025 · DK · contact PI
Administrative Core$157,908
P30 · FY2025 · DK · contact PI
Personalized Cystic Fibrosis Therapy and Research Center$944,438
P30 · FY2024 · DK · contact PI
Inhibition of an Apical cAMP/cGMP Transporter (MRP4) in the Gut Induces Diarrhea$606,584
R01 · FY2024 · DK · contact PI
Personalized Cystic Fibrosis Therapy and Research Center$203,330
P30 · FY2024 · DK · contact PI
Personalized Cystic Fibrosis Therapy and Research Center$965,562
P30 · FY2023 · DK · contact PI
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR$423,755
R01 · FY2023 · HL · contact PI
Personalized Cystic Fibrosis Therapy and Research Center$218,455
P30 · FY2023 · DK · contact PI
Personalized Cystic Fibrosis Therapy and Research Center$1,137,847
P30 · FY2022 · DK · contact PI
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR$423,702
R01 · FY2022 · HL · contact PI
Inhibition of an Apical cAMP/cGMP Transporter(MRP4)in the Gut InducesDiarrhea$375,451
R01 · FY2022 · DK · contact PI
Core-003$229,274
P30 · FY2022 · DK · contact PI
Personalized Model System Core$226,050
P30 · FY2022 · DK · contact PI
Administrative Core$198,655
P30 · FY2022 · DK · contact PI
Personalized Cystic Fibrosis Therapy and Research Center$1,144,093
P30 · FY2021 · DK · contact PI
Investigating of the Mechanisms of Action of CFTR Correctors in RescuingDelta F508-CFTR$440,342
R01 · FY2021 · HL · contact PI
Inhibition of an Apical cAMP/cGMP Transporter(MRP4)in the Gut InducesDiarrhea$392,507
R01 · FY2021 · DK · contact PI
Core-003$231,301
P30 · FY2021 · DK · contact PI
Personalized Model System Core$226,307
P30 · FY2021 · DK · contact PI
Administrative Core$198,938
P30 · FY2021 · DK · contact PI
Personalized Cystic Fibrosis Therapy and Research Center$1,158,088
P30 · FY2020 · DK · contact PI
Investigating of the Mechanisms of Action of CFTR Correctors in Rescuing Delta F508-CFTR$422,302
R01 · FY2020 · HL · contact PI
Inhibition of an Apical cAMP/cGMP Transporter(MRP4)in the Gut Induces Diarrhea$360,518
R01 · FY2020 · DK · contact PI
Preclinical characterization of saracatinib for cystic fibrosis therapy$357,751
UH3 · FY2020 · TR
Core-003$233,598
P30 · FY2020 · DK · contact PI
Personalized Model System Core$226,871
P30 · FY2020 · DK · contact PI
Administrative Core$199,483
P30 · FY2020 · DK · contact PI
Personalized Cystic Fibrosis Therapy and Research Center$1,163,071
P30 · FY2019 · DK · contact PI
Inhibition of an Apical cAMP/cGMP Transporter(MRP4)in the Gut Induces Diarrhea$360,518
R01 · FY2019 · DK · contact PI
LPA2 receptor-containing complexes in regulating secretory diarrhea$351,000
R01 · FY2019 · DK · contact PI
Preclinical characterization of saracatinib for cystic fibrosis therapy$318,000
UG3 · FY2019 · TR
Personalized Model System Core$228,507
P30 · FY2019 · DK · contact PI
Administrative Core$191,347
P30 · FY2019 · DK · contact PI
Personalized Cystic Fibrosis Therapy and Research Center$1,174,280
P30 · FY2018 · DK · contact PI
Inhibition of an Apical cAMP/cGMP Transporter(MRP4)in the Gut Induces Diarrhea$373,793
R01 · FY2018 · DK · contact PI
LPA2 receptor-containing complexes in regulating secretory diarrhea$351,000
R01 · FY2018 · DK · contact PI
Preclinical characterization of saracatinib for cystic fibrosis therapy$318,000
UG3 · FY2018 · TR
Personalized Model System Core$237,430
P30 · FY2018 · DK · contact PI
Administrative Core$191,347
P30 · FY2018 · DK · contact PI
LPA2 receptor-containing complexes in regulating secretory diarrhea$351,000
R01 · FY2017 · DK · contact PI
Inhibition of an apical cAMP/cGMP transporter(MRP4)in the gut induces diarrhea$333,363
R01 · FY2017 · DK · contact PI
Human Enteroids, Colonoids, and iPSC derived HIO's to study CFTR-relatedDisorders$102,448
R56 · FY2017 · DK · contact PI
LPA2 receptor-containing complexes in regulating secretory diarrhea$351,000
R01 · FY2016 · DK · contact PI
Inhibition of an apical cAMP/cGMP transporter(MRP4)in the gut induces diarrhea$333,536
R01 · FY2016 · DK · contact PI
LPA2 receptor-containing complexes in regulating secretory diarrhea$351,000
R01 · FY2015 · DK · contact PI
Inhibition of an apical cAMP/cGMP transporter(MRP4)in the gut induces diarrhea$340,664
R01 · FY2015 · DK · contact PI
Inhibition of an apical cAMP/cGMP transporter(MRP4)in the gut induces diarrhea$346,640
R01 · FY2014 · DK · contact PI
LPA2 receptor-containing complexes in regulating secretory diarrhea$305,370
R01 · FY2014 · DK · contact PI
LPA2 receptor-containing complexes in regulating secretory diarrhea$287,237
R01 · FY2013 · DK · contact PI
Inhibition of an apical cAMP/cGMP transporter(MRP4)in the gut induces diarrhea$223,848
R01 · FY2013 · DK · contact PI
Inhibition of an apical cAMP/cGMP transporter(MRP4)in the gut induces diarrhea$117,864
R01 · FY2013 · DK · contact PI
LPA2 receptor-containing complexes in regulating secretory diarrhea$7,160
R01 · FY2013 · DK · contact PI
Inhibition of an apical cAMP transporter (MRP4) in the gut induces diarrhea$316,253
R01 · FY2012 · DK · contact PI
LPA2 receptor-containing complexes in regulating secretory diarrhea$293,625
R01 · FY2012 · DK · contact PI
LPA2 receptor-containing complexes in regulating secretory diarrhea$336,375
R01 · FY2011 · DK · contact PI
Inhibition of an apical cAMP transporter (MRP4) in the gut induces diarrhea$319,144
R01 · FY2011 · DK · contact PI
Inhibition of an apical cAMP transporter (MRP4) in the gut induces diarrhea$362,371
R01 · FY2010 · DK · contact PI
Inhibition of an apical cAMP transporter (MRP4) in the gut induces diarrhea$364,479
R01 · FY2009 · DK · contact PI
CFTR-dependent protein interactions regulate diarrhea$257,021
R01 · FY2009 · DK · contact PI
Inhibition of an apical cAMP transporter (MRP4) in the gut induces diarrhea$71,755
R01 · FY2009 · DK · contact PI
CFTR-dependent protein interactions regulate diarrhea$257,021
R01 · FY2008 · DK · contact PI
Vibrio Cholerae as a bioterror agent: New means of treating a potential pandemic$71,613
R03 · FY2008 · AI · contact PI
CFTR-dependent protein interactions regulate diarrhea$262,267
R01 · FY2007 · DK · contact PI
Vibrio Cholerae as a bioterror agent: New means of treating a potential pandemic$73,000
R03 · FY2007 · AI · contact PI
CFTR-dependent protein interactions regulate diarrhea$289,870
R01 · FY2006 · DK · contact PI
Identifying molecules that augment mutant CFTR activity$208,761
R01 · FY2006 · DK · contact PI
Identifying molecules that augment mutant CFTR activity$213,785
R01 · FY2005 · DK
Identifying molecules that augment mutant CFTR activity$213,785
R01 · FY2004 · DK
Identifying molecules that augment mutant CFTR activity$213,785
R01 · FY2003 · DK
Identifying molecules that augment mutant CFTR activity$262,284
R01 · FY2002 · DK